Found: 27
Select item for more details and to access through your institution.
Erythromycin Estolate vs. Erythromycin Base, Surface Excess Properties and Surface Scanning Changes in Isolated Liver Cell Systems.
- Published in:
- Pharmacology, 1980, v. 20, n. 6, p. 285, doi. 10.1159/000137382
- By:
- Publication type:
- Article
Relationship between Surface Activity and Toxicity to Chang Liver Cultures of Tricyclic Antidepressants.
- Published in:
- Pharmacology, 1979, v. 18, n. 2, p. 95, doi. 10.1159/000137236
- By:
- Publication type:
- Article
Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia.
- Published in:
- JAMA: Journal of the American Medical Association, 1999, v. 281, n. 2, p. 137, doi. 10.1001/jama.281.2.137
- By:
- Publication type:
- Article
Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Essentials of Therapeutic Drug Monitoring (Book).
- Published in:
- 1984
- By:
- Publication type:
- Book Review
Probucol with Colestipol in the Treatment of Hypercholesterolemia.
- Published in:
- Annals of Internal Medicine, 1984, v. 100, n. 4, p. 477, doi. 10.7326/0003-4819-100-4-477
- By:
- Publication type:
- Article
Goodman and Gilman's The Pharmacological Basis of Therapeutics (Book).
- Published in:
- 1981
- By:
- Publication type:
- Book Review
Experimental Production of Diseases (Book).
- Published in:
- 1978
- By:
- Publication type:
- Book Review
What Combination Therapy with a Statin, If Any, Would You Recommend?
- Published in:
- Current Atherosclerosis Reports, 2011, v. 13, n. 1, p. 12, doi. 10.1007/s11883-010-0150-3
- By:
- Publication type:
- Article
Pleiotropic effects: Should statins be considered an essential component in the treatment of dyslipidemia?
- Published in:
- Current Atherosclerosis Reports, 2008, v. 10, n. 1, p. 45, doi. 10.1007/s11883-008-0008-0
- By:
- Publication type:
- Article
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.
- Published in:
- Current Atherosclerosis Reports, 2006, v. 8, n. 2, p. 144, doi. 10.1007/s11883-006-0052-6
- By:
- Publication type:
- Article
Probucol.
- Published in:
- Current Atherosclerosis Reports, 2000, v. 2, n. 1, p. 47, doi. 10.1007/s11883-000-0094-0
- By:
- Publication type:
- Article
Hepatotoxicity of General Anesthetics on Rat Hepatoma Cells in Culture<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1976, v. 151, n. 4, p. 789, doi. 10.3181/00379727-151-39308
- By:
- Publication type:
- Article
Cytotoxicity of Phenothiazines on Chang Liver Cells as Measured by Enzyme Leakage.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1969, v. 131, n. 2, p. 583, doi. 10.3181/00379727-131-33931
- By:
- Publication type:
- Article
Effects of the ACAT inhibitor CL 277,082 on cholesterol metabolism in humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 48, n. 2, p. 189, doi. 10.1038/clpt.1990.134
- By:
- Publication type:
- Article
Lipid effects of celiprolol, a new cardioselective β-blocker, versus propranolol.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 45, n. 6, p. 617, doi. 10.1038/clpt.1989.82
- By:
- Publication type:
- Article
Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation.
- Published in:
- Clinical Pharmacology & Therapeutics, 1988, v. 44, n. 3, p. 320, doi. 10.1038/clpt.1988.157
- By:
- Publication type:
- Article
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 11, p. 509, doi. 10.1002/clc.4960261106
- By:
- Publication type:
- Article
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 1, p. 18, doi. 10.1002/clc.4960260105
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Primary Hypercholesterolemia.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S4, p. 1, doi. 10.1002/clc.4960240902
- By:
- Publication type:
- Article
Reduction of LDL Cholesterol in Patients with Primary Hypercholesterolemia by SCH 48461: Results of a Multicenter Dose-Ranging Study.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 1, p. 70, doi. 10.1177/009127000104100i108
- By:
- Publication type:
- Article
Hepatotoxicity of Phenothiazines in Vitro as Measured by Loss of Aminotransferases to Surrounding Media∗.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1968, v. 128, n. 2, p. 561, doi. 10.3181/00379727-128-33066
- By:
- Publication type:
- Article
Drug intervention trials in dyslipidemia: The past and the future:: C. A. Dujovne: Lipid-drug trials.
- Published in:
- Clinical Cardiology, 1991, v. 14, n. S1, p. 48, doi. 10.1002/clc.4960141308
- By:
- Publication type:
- Article
Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.
- Published in:
- Clinical Pharmacology & Therapeutics, 1984, v. 36, n. 2, p. 157, doi. 10.1038/clpt.1984.156
- By:
- Publication type:
- Article
Quantitation of biliary excretion of drugs in man.
- Published in:
- Clinical Pharmacology & Therapeutics, 1982, v. 31, n. 2, p. 187, doi. 10.1038/clpt.1982.30
- By:
- Publication type:
- Article
Cholestyramine and spironolactone and their combination in digitoxin elimination.
- Published in:
- Clinical Pharmacology & Therapeutics, 1980, v. 27, n. 2, p. 184, doi. 10.1038/clpt.1980.28
- By:
- Publication type:
- Article
Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial.
- Published in:
- 1996
- By:
- Publication type:
- journal article